0000899243-22-037232.txt : 20221130
0000899243-22-037232.hdr.sgml : 20221130
20221130183136
ACCESSION NUMBER: 0000899243-22-037232
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221128
FILED AS OF DATE: 20221130
DATE AS OF CHANGE: 20221130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Amello Jason
CENTRAL INDEX KEY: 0001451805
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40629
FILM NUMBER: 221436626
MAIL ADDRESS:
STREET 1: 500 KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 01824
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Candel Therapeutics, Inc.
CENTRAL INDEX KEY: 0001841387
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 522214851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 117 KENDRICK STREET
STREET 2: SUITE 450
CITY: NEEDHAM
STATE: MA
ZIP: 02494
BUSINESS PHONE: 617-916-5445
MAIL ADDRESS:
STREET 1: 117 KENDRICK STREET
STREET 2: SUITE 450
CITY: NEEDHAM
STATE: MA
ZIP: 02494
FORMER COMPANY:
FORMER CONFORMED NAME: Candel Therapeutics, Inic.
DATE OF NAME CHANGE: 20210120
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-11-28
0
0001841387
Candel Therapeutics, Inc.
CADL
0001451805
Amello Jason
C/O CANDEL THERAPEUTICS, INC.
117 KENDRICK ST., SUITE 450
NEEDHAM
MA
02494
0
1
0
0
Chief Financial Officer
Common Stock
2022-11-28
4
A
0
90877
0.00
A
90877
D
Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting and settlement. 50% of the RSUs shall vest on November 28, 2023, and the remaining 50% on November 28, 2024, in each case subject to the Reporting Person's continued service on such vesting date.
/s/ Jason Amello
2022-11-30